LCN2 and cancer: Soon after the discovery of lipocalin-2 as a constituent of neutrophil specific granules, lipocalin-2 was found to be highly up-regulated in epithelial cells at sites of inflammation [8]–[10] and to be highly expressed in some cancers [4], [11]–[13].